Explore the latest in ischemic heart disease, including advances in PCI and in the diagnosis and management of acute coronary syndromes.
This cohort study examines the association between Mediterranean diet intake and cardiovascular risks and attempts to identify which biological mechanisms underlie the association among participants of the Women’s Health Study.
This cohort study evaluates the association of adherence and treatment intensity with cardiovascular outcomes in patients with documented cardiovascular disease, type 2 diabetes without cardiovascular disease or chronic kidney disease, and chronic kidney disease without cardiovascular disease.
This editorial comments on recent data that show a mortality gap between individuals with and without schizophrenia, with changes in the disparity as the amount of medical care given increases.
This study uses the Danish nationwide health care registries to investigate the association of secondary preventive cardiovascular treatment with all-cause mortality after myocardial infarction in patients with schizophrenia compared with those without schizophrenia.
This secondary analysis of the Examining Use of Ticagrelor in Peripheral Artery Disease (EUCLID) trial examines the risk of ischemic events in patients with peripheral artery disease (PAD) and polyvascular disease (PAD with coronary artery disease [CAD] and/or cerebrovascular disease [CVD]).
This cross-sectional study examines 30-day risk-standardized mortality rates for coronary artery bypass grafting, acute myocardial infarction, and heart failure at top-ranked US News & World Report cardiology vs nonranked hospitals.
This cohort study determines the rate of return to work among Chinese patients within 12 months after acute myocardial infarction, classifies the reasons why patients did not return to work, and identifies patient factors associated with returning to work after acute myocardial infarction.
This pilot study assesses the accuracy of predictions made in 2001 by expert clinicians and researchers on technologic innovations in therapy for Alzheimer disease and cardiovascular disease by 2021.
A 36-year-old gravida 3, para 3 woman who had elective cesarean delivery 11 days prior presented with 3 days of exertional chest pain, an elevated troponin I level, ST-segment depression on electrocardiography, and coronary artery dissection on angiography. What would you do next?
This systematic review and meta-analysis evaluates evidence from mendelian randomization studies to provide a less biased estimate of any association between obesity and cardiometabolic outcomes, specifically coronary artery disease, stroke, or type 2 diabetes, among nearly 1 million participants.
This secondary analysis of a randomized clinical trial assesses if different biomarkers provide information about the risk for all-cause and cause-specific mortality after acute coronary syndrome.
This cohort study uses data from 2 US myocardial infarction registries to assess whether demographic or clinical characteristics differ between self-identified black patients and white patients or are associated with 1- or 5-year survival after acute myocardial infarction.
This cohort study of community-dwelling, elderly individuals in Iceland examines the association of unrecognized myocardial infarction by cardiovascular magnetic resonance imaging with major adverse cardiac events, such as death, nonfatal myocardial infarction, and heart failure.
This cohort study compares the efficacy of a novel point-of-care troponin assay with an established assay in patients with possible acute myocardial infarction.
This secondary analysis of a randomized clinical trial investigates whether periprocedural loading doses of atorvastatin are associated with decreased 30-day major adverse cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: